tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ami Fadia, 414 are a BUY (88.09%), 52 are a HOLD (11.06%), 4 are a SELL (0.85%).
Analyst Ami Fadia, currently employed at NEEDHAM, carries an average stock price target met ratio of 44.9% that have a potential upside of 36.94% achieved within 194 days.
Ami Fadia’s has documented 888 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 24-Nov-2025.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 10/12/2023. The price target of $34 was fulfilled within 4 days with a profit of $9.8 (40.5%) receiving and performance score of 101.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$12
$-4.14 (-25.65%)
$7
5 months 11 days ago
(25-Jun-2025)
8/13 (61.54%)
$-4.19 (-25.88%)
55
Buy
1 years 5 months 18 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
2 years 16 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$3.86 (23.92%)
$60
2 years 1 months 11 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$8.86 (54.89%)
$40
2 years 4 months 17 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Ami Fadia is most bullish on?
Which stock is Ami Fadia is most reserved on?
What Year was the first public recommendation made by Ami Fadia?
